课题基金 / 基金详情

HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING

HUNTINGTIN MICROAGGREGATES AND CELL TOXICITY: LIVE CELL IMAGING
亨廷顿微聚集体和细胞毒性:活细胞成像
批准号:
7722441
负责人:
Christopher A Ross
金额:
$0.98万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2009-04-30

项目摘要

项目成果

Christopher A Ross的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Huntingtin inclusion bodies are found postmortem in Huntington¿s disease patients. However it was previously shown that huntingtin inclusion body formation reduces the risk of neuronal death. Our hypothesis is that huntingtin microaggregates are responsible for neurotoxicity, and could serve as a target for therapeutic intervention. To test this hypothesis, we are expressing huntingtin exon-1 with a tetra cysteine tag in neuronal cell lines and using live cell imaging to quantify the conversion of soluble huntingtin into aggregates and its effect on cell toxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LRRK2 and inflammasome pathway in Parkinson's disease
  • 批准号:
    10292714
  • 项目类别:
  • 资助金额:
    $67.31万
  • 财政年份:
    2021
  • 负责人:
    Christopher A Ross
  • 依托单位:
LRRK2 and inflammasome pathway in Parkinson's disease
  • 批准号:
    10432114
  • 项目类别:
  • 资助金额:
    $65.86万
  • 财政年份:
    2021
  • 负责人:
    Christopher A Ross
  • 依托单位:
LRRK2 and inflammasome pathway in Parkinson's disease
  • 批准号:
    10640900
  • 项目类别:
  • 资助金额:
    $64.29万
  • 财政年份:
    2021
  • 负责人:
    Christopher A Ross
  • 依托单位:
Immortalized Striatal Precursor Neurons as a Screenable Model of HD
  • 批准号:
    10550333
  • 项目类别:
  • 资助金额:
    $40.94万
  • 财政年份:
    2018
  • 负责人:
    Christopher A Ross
  • 依托单位:
海外基金